Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
Status: | Active, not recruiting |
---|---|
Conditions: | Peripheral Vascular Disease, Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - 85 |
Updated: | 2/3/2019 |
Start Date: | June 2013 |
End Date: | March 2019 |
Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery
The investigator goal is to evaluate the effects of intraoperative and postoperative
dexmedetomidine sedation (versus placebo after cardiac surgery.
dexmedetomidine sedation (versus placebo after cardiac surgery.
Inclusion Criteria:
1. 18-85 years old;
2. Scheduled for cardiac surgery with bypass (CABG, valve, or combined);
3. Able to provide a written informed consent;
4. Hemodynamically stable (heart rate>= 55).
Exclusion Criteria:
1. Sick sinus syndrome or Wolff-Parkinson-White syndrome
2. Atrio-ventricular block
3. Hypersensitivity or known allergy to dexmedetomidine
4. Hepatic disease, e.g. twice the normal level of liver enzymes
5. AF within 1 preoperative month;
6. Permanent pacemaker;
7. Use of amiodarone or dexmedetomidine within the last 30 days;
8. Patients with an ejection fraction under 30% or who had severe heart failure
9. Myocardial infarction in the previ¬ous 7 days;
10. Body mass index =< 40 (BMI= mass (kg) / height (m)2);
11. Those tak¬ing clonidine within last 48 hours.
We found this trial at
1
site
Cleveland, Ohio 44195
Principal Investigator: Alparslan Turan, MD
Phone: 216-444-9950
Click here to add this to my saved trials